Best practices in creating campaigns
In the text boxes, shoot for a minimum of 25, and up to 250 words. the general rule is that the more dense with industry jargon, the better. Here’s a good example of what we suggested on client include (and exclude):
“Epitel is a digital health company that develops artificial intelligence solutions for monitoring brain health. Epitel’s flagship
product is Epilog, a hardware-enabled data analytics platform that brings medical-grade seizure monitoring into the homes of people living with epilepsy for the first time. EEG-based monitoring is the gold standard for seizure detection, but has never been available outside of the hospital until now. Epitel is a market leader in seizure detection, with the world’s largest and fastest-growing proprietary EEG seizure monitoring database, and a powerful suite of analytics and algorithms.
70% grant-funded for the next two years, and is looking to accelerate its data collection, platform development, and regulatory clearance with a $500k SAFE in early 2019 and a follow-on $3.5 investment round at the end of 2019.”
THE EPILOG EXPERIENCE: SEIZURE CERTAINTY WHERE YOU ARE
• Medical-grade seizure detection outside of the hospital
• Real-time detection, alerting & prediction (NOT a biomarker)
• Discrete & non-invasive
• Affordable: $350-380/year (before reimbursement)
• Real-time monitoring that connects patients and caregivers
through a mobile app
EPILOG MARKET OPPORTUNITY
There are 3.4 million in the U.S. and over 70 million epilepsy.
people worldwide living with
• Epilepsy is the 4th most common neurological
disorder – more common than Autism, Parkinson’s
disease, Multiple Sclerosis and Cerebral Palsy combined
• 1 in 26 people will develop epilepsy, of which 60%
have no known cause
Epilog’s target addressable market is 40% – people living
with epilepsy who are unable to control their seizures.
Epilog will launch initially through our thought leader clinical
partners and will grow through digital marketing,
epileptologists and clinics, and our relationships with the
world’s leading epilepsy foundations.
In the United States, this translates to 1.5 million
people – a $580 million market.
• Globally (US, EU, JP & AU), this translates to 4.3
million people – a $1.7 billion market.
Epitel’s active clinical studies are the foundation of creating
the world’s largest and most comprehensive device-driven
proprietary EEG seizure database, with machine learning
algorithms for detection, alerting, and predicting seizure
events. Epitel is a pioneer in low-power EEG hardware and
an advanced prototype is currently in use in clinical studies
for children and adults at three level 4 epilepsy centers and
three pharmaceutical clinical trials.